BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1461844)

  • 1. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
    Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
    Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
    [No Abstract]   [Full Text] [Related]  

  • 2. Isoenzymes of N-acetyl-beta-hexosaminidase.
    Zwierz K; Zalewska A; Zoch-Zwierz A
    Acta Biochim Pol; 1999; 46(3):739-51. PubMed ID: 10698282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism.
    Sango K; Yamanaka S; Hoffmann A; Okuda Y; Grinberg A; Westphal H; McDonald MP; Crawley JN; Sandhoff K; Suzuki K; Proia RL
    Nat Genet; 1995 Oct; 11(2):170-6. PubMed ID: 7550345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history and inherited disorders of a lysosomal enzyme, beta-hexosaminidase.
    Neufeld EF
    J Biol Chem; 1989 Jul; 264(19):10927-30. PubMed ID: 2525553
    [No Abstract]   [Full Text] [Related]  

  • 5. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases.
    Phaneuf D; Wakamatsu N; Huang JQ; Borowski A; Peterson AC; Fortunato SR; Ritter G; Igdoura SA; Morales CR; Benoit G; Akerman BR; Leclerc D; Hanai N; Marth JD; Trasler JM; Gravel RA
    Hum Mol Genet; 1996 Jan; 5(1):1-14. PubMed ID: 8789434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemical basis of gangliosidoses.
    Sandhoff K; Conzelmann E
    Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genetic deficiencies of beta-N-acetylhexosaminidase A and B: Tay-Sachs and Sandhoff diseases (GM2-gangliosidosis)].
    Suzuki K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):721-7. PubMed ID: 2978703
    [No Abstract]   [Full Text] [Related]  

  • 8. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
    Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
    ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances in molecular genetics of GM2 gangliosidosis].
    Wakamatsu N
    Nihon Rinsho; 1995 Dec; 53(12):2988-93. PubMed ID: 8577047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.
    Norflus F; Yamanaka S; Proia RL
    DNA Cell Biol; 1996 Feb; 15(2):89-97. PubMed ID: 8634145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ assessment of beta-hexosaminidase activity.
    Lacorazza HD; Jendoubi M
    Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.
    Tropak MB; Reid SP; Guiral M; Withers SG; Mahuran D
    J Biol Chem; 2004 Apr; 279(14):13478-87. PubMed ID: 14724290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
    Tse R; Vavougios G; Hou Y; Mahuran DJ
    Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
    Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
    J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel beta-hexosaminidase A mutations in obligate carriers of Tay-Sachs disease.
    Tomczak J; Grebner EE
    Hum Mutat; 1994; 4(1):71-2. PubMed ID: 7951261
    [No Abstract]   [Full Text] [Related]  

  • 17. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease.
    McInnes B; Brown CA; Mahuran DJ
    Biochim Biophys Acta; 1992 Apr; 1138(4):315-7. PubMed ID: 1532910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel HEXA mutation [1393G>A (D465N)] in a Mexican Tay-Sachs disease patient.
    Alvarez-Rodríguez A; Triggs-Raine B; Barros-Núñez P; Lozano CM
    Hum Mutat; 2001 May; 17(5):437. PubMed ID: 11317368
    [No Abstract]   [Full Text] [Related]  

  • 20. GM2 gangliosidoses: a review of cases confirmed by beta-N-acetylhexosaminidase assay.
    Christopher R; Rangaswamy GR; Shetty KT
    Indian J Pediatr; 1995; 62(4):479-83. PubMed ID: 10829909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.